Bone News and Research

RSS

Changing the size and number of pores in processed foods can reduce salt intake

Two University of Illinois food scientists have learned that understanding and manipulating porosity during food manufacturing can affect a food's health benefits.

10 Apr 2015

Amniotic stem cells promote growth of functional blood vessels in healing hydrogels

Rice University and Texas Children's Hospital scientists are using stem cells from amniotic fluid to promote the growth of robust, functional blood vessels in healing hydrogels.

10 Apr 2015

Pharmacyclics announces positive results from IMBRUVICA Phase II study in WM patients

Pharmacyclics, Inc. today announced longer-term data from a Phase II investigator-initiated study showing Waldenstrom's macroglobulinemia (WM) patients treated with IMBRUVICA (ibrutinib) experienced sustained disease control with an overall response rate (ORR) of 91% after a median of 19.1 months of treatment and a 2-year overall survival (OS) rate of 95%.

9 Apr 2015

$Incidence, costs of osteoporotic fractures in China to double by 2035$

Incidence, costs of osteoporotic fractures in China to double by 2035

The results of the first study using a health economics model to project osteoporosis-related fractures and costs for the Chinese population, shows that the country's healthcare system will face a dramatic rise in costs over the next few decades.

8 Apr 2015

American Oil Chemists' Society honors UMass Amherst food scientist

The American Oil Chemists' Society has honored University of Massachusetts Amherst food scientist Yeonhwa Park with the Timothy L. Mounts Award for her "significant and important contributions in the area of bioactive lipids and their impact on health conditions such as obesity, osteoporosis, arthritis and cardiovascular disease."

8 Apr 2015

Cerapedics closes $4 million term loan, raises additional $4 million in equity financing

Cerapedics, a privately-held orthobiologics company, today announced closing of a $4 million term loan from GE Capital, Healthcare Financial Services, bringing the total facility to $16.5 million. The company also announced it recently raised an additional $4 million in equity financing from inside investors.

7 Apr 2015

Younger patients can benefit from ACL surgery

A new study appearing in the April issue of The Journal of Bone & Joint Surgery (JBJS), found that most patients who underwent surgery to repair and rebuild an anterior cruciate ligament (ACL) tear, showed significant improvement in physical function at two years, which continued for at least six years following surgery.

7 Apr 2015

Scientists discover molecular switch that ‘turns off’ HCMV

Human cytomegalovirus (HCMV) is an extremely common virus, which as other members of the herpes virus family causes life-long infections in humans. Most individuals are exposed to HCMV during childhood, yet symptoms can be easily fought off by a healthy immune system.

7 Apr 2015

Clinical trial uses personalized cellular therapy to treat GVHD complication of bone marrow transplant

An innovative clinical trial using the science of "personalized" cellular therapy has begun enrolling children and adults suffering from graft-versus-host-disease (GVHD), a life-threatening complication of bone marrow transplantation in which donor immune lymphocytes attack the organs of the bone marrow transplant recipient.

3 Apr 2015

Researchers pinpoint molecular mechanisms that inhibit Hippo pathway in pediatric bone cancers

A particular molecular pathway permits stem cells in pediatric bone cancers to grow rapidly and aggressively, according to researchers at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center.

2 Apr 2015

Astellas Pharma, Medivation announce topline results from enzalutamide Phase 2 STRIVE trial

Astellas Pharma Inc. and Medivation, Inc. today announced topline results from the Phase 2 STRIVE trial comparing enzalutamide with bicalutamide in a study population of men with non-metastatic or metastatic castration-resistant prostate cancer.

2 Apr 2015

Treating common gum disease in CKD patients could reduce heart disease risk

Treating a common gum condition in chronic kidney disease (CKD) patients could significantly reduce their risk of potentially fatal heart disease, Aston University researchers say.

2 Apr 2015

Novel molecule inhibits cancer-causing transcription factors

A novel molecule designed by scientists at the University of Massachusetts Medical School and the University of Virginia inhibits progression of a hard-to-treat form of recurring acute myeloid leukemia (AML) in patient tissue.

2 Apr 2015

Low doses of imatinib drug can push immune system to combat bacterial infections

Low doses of the anti-cancer drug imatinib can spur the bone marrow to produce more innate immune cells to fight against bacterial infections, Emory researchers have found.

1 Apr 2015

Combined therapy boosts growth in short children with low IGF-1

Children with short stature benefit from receiving combined treatment with growth hormone and insulin-like growth factor-1, if they have low endogenous levels of the latter, a study shows.

1 Apr 2015

Idiopathic central precocious puberty on the rise in boys

About three-quarters of cases of central precocious puberty in boys have no identifiable cause, say researchers.

1 Apr 2015

BME announces launch of Speed Titan Nitinol Bone Fixation Implant

BioMedical Enterprises announced the launch of the Speed Titan Nitinol Bone Fixation Implant today. As the newest addition to the BME Speed Fixation System, the Speed Titan joins the BME Speed, Speed Arc and Speed Shift™ implants to create the world's most comprehensive family of continuous active compression Nitinol implants.

1 Apr 2015

Shire announces availability of Natpara (parathyroid hormone) for injection in U.S.

Shire plc today announced that Natpara (parathyroid hormone) for injection is now available in the United States. The U.S. Food and Drug Administration approved Natpara as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism on January 23, 2015.

1 Apr 2015

Johns Hopkins researchers find link between premature aging of telomere and lung diseases

Lung diseases like emphysema and pulmonary fibrosis are common among people with malfunctioning telomeres, the “caps” or ends of chromosomes. Now, researchers from Johns Hopkins say they have discovered what goes wrong and why.

1 Apr 2015

Johns Hopkins researchers find link between premature aging of telomere and lung diseases

1 Apr 2015

Bone News and Research

Changing the size and number of pores in processed foods can reduce salt intake

Amniotic stem cells promote growth of functional blood vessels in healing hydrogels

Pharmacyclics announces positive results from IMBRUVICA Phase II study in WM patients

Incidence, costs of osteoporotic fractures in China to double by 2035

American Oil Chemists' Society honors UMass Amherst food scientist

Cerapedics closes $4 million term loan, raises additional $4 million in equity financing

Younger patients can benefit from ACL surgery

Scientists discover molecular switch that ‘turns off’ HCMV

Clinical trial uses personalized cellular therapy to treat GVHD complication of bone marrow transplant

Researchers pinpoint molecular mechanisms that inhibit Hippo pathway in pediatric bone cancers

Astellas Pharma, Medivation announce topline results from enzalutamide Phase 2 STRIVE trial

Treating common gum disease in CKD patients could reduce heart disease risk

Novel molecule inhibits cancer-causing transcription factors

Low doses of imatinib drug can push immune system to combat bacterial infections

Combined therapy boosts growth in short children with low IGF-1

Idiopathic central precocious puberty on the rise in boys

BME announces launch of Speed Titan Nitinol Bone Fixation Implant

Shire announces availability of Natpara (parathyroid hormone) for injection in U.S.

Johns Hopkins researchers find link between premature aging of telomere and lung diseases

Johns Hopkins researchers find link between premature aging of telomere and lung diseases

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News